CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
227.5 SEK
0.89%
Market Closed
Updated:
May 3, 2024
CellaVision AB
Cash from Investing Activities
|
CellaVision AB
Cash from Investing Activities Peer Comparison
Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Cash from Investing Activities
-kr85.5m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-22%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Cash from Investing Activities
-kr1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Cash from Investing Activities
-kr6.5B
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Cash from Investing Activities
-kr637m
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Elos Medtech AB
STO:ELOS B
|
Cash from Investing Activities
-kr117.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Cash from Investing Activities
-kr322m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Cash from Investing Activities?
Cash from Investing Activities
-85.5m
SEK
-85.5m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Cash from Investing Activities amounts to -85.5m SEK.
What is CellaVision AB's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-22%
-22%
Over the last year, the Cash from Investing Activities growth was -22%. The average annual Cash from Investing Activities growth rates for CellaVision AB have been -35% over the past three years , -29% over the past five years , and -22% over the past ten years .
You don't have any saved screeners yet
